GGrantIndex
← Leaderboards

Cynthia Melinda Boyd

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗
$13,738,237
Attributed
$23,749,636
Total exposure
14
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.5M · FY2008–25
$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,200,166 · 12
AHRQ$549,470 · 2

By mechanism

R24$9,867,506 · 1
R33$3,920,186 · 2
T32$3,261,894 · 1
RF1$1,923,910 · 1
P30$1,535,668 · 3
K24$1,108,574 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Caring”

Research focus

CaringElderlyPharmaceutical PreparationsAlzheimer&AposPersonsAgingPatient OrientedFamilyResourcesResearch PersonnelMultiple Chronic ConditionsCaregiversFundingStructurePrevalencePilot ProjectsInnovationCareerBasePrimary Health CareProgramsDecision MakingPolypharmacyGuidelines

Grant awards (48)

The U.S. Deprescribing Research Network$809,610
R33 · FY2025 · AG
Health Services and Outcomes Research for Aging Populations$499,598
T32 · FY2025 · AG
Program Development Pilot Core$239,164
P30 · FY2025 · AG · contact PI
The U.S. Deprescribing Research Network$871,043
R33 · FY2024 · AG
Health Services and Outcomes Research for Aging Populations$578,425
T32 · FY2024 · AG
Generating Evidence on Deprescribing Safety$541,565
R01 · FY2024 · AG
Program Development (Pilot) Core$246,246
P30 · FY2024 · AG · contact PI
U.S. Deprescribing Research Network$1,507,522
R24 · FY2023 · AG
Health Services and Outcomes Research for Aging Populations$558,557
T32 · FY2023 · AG
Adapting the ShedMEDS Deprescribing Intervention to Dementia Care in Assisted Living$345,479
R24 · FY2023 · AG
Program Development (Pilot) Core$313,281
P30 · FY2023 · AG · contact PI
Health Services and Outcomes Research for Aging Populations$82,799
T32 · FY2023 · AG
U.S. Deprescribing Research Network$1,502,779
R24 · FY2022 · AG
Pilot studies of complementary and integrative health approaches to support benzodiazepine deprescribing in older adults with the US Deprescribing Research Network$900,400
R24 · FY2022 · AG
Health Services and Outcomes Research for Aging Populations$535,484
T32 · FY2022 · AG
Priorities Aligned Deprescribing for Persons Living with Dementia and their Caregivers$334,771
R24 · FY2022 · AG
Program Development (Pilot) Core$246,246
P30 · FY2022 · AG · contact PI
Generating Evidence on Deprescribing Safety$1,923,910
RF1 · FY2021 · AG
U.S. Deprescribing Research Network$1,524,556
R24 · FY2021 · AG
Optimal Medication Management in Alzheimer's Disease and Dementia$619,216
R33 · FY2021 · AG
Health Services and Outcomes Research for Aging Populations$507,047
T32 · FY2021 · AG
Identifying caregivers for deprescribing pragmatic trials$274,268
R24 · FY2021 · AG
Program Development (Pilot) Core$246,246
P30 · FY2021 · AG · contact PI
Assessment of Medication Optimization in Rural Kentucky Appalachian patients with mild cognitive impairment or dementia: The AMOR Kentucky Study$238,366
R24 · FY2021 · AG
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring Program$187,938
K24 · FY2021 · AG · contact PI
U.S. Deprescribing Research Network$1,544,614
R24 · FY2020 · AG
Optimal Medication Management in Alzheimer's Disease and Dementia$623,368
R33 · FY2020 · AG
Health Services and Outcomes Research for Aging Populations$499,984
T32 · FY2020 · AG
Program Development (Pilot) Core$244,485
P30 · FY2020 · AG · contact PI
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring Program$187,938
K24 · FY2020 · AG · contact PI
U.S. Deprescribing Research Network$1,694,751
R24 · FY2019 · AG
Optimal Medication Management in Alzheimer's Disease and Dementia$836,138
R33 · FY2019 · AG
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring Program$187,938
K24 · FY2019 · AG · contact PI
Optimal Medication Management in Alzheimer's Disease and Dementia$160,811
R33 · FY2019 · AG
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring Program$187,938
K24 · FY2018 · AG · contact PI
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring Program$168,884
K24 · FY2018 · AG · contact PI
Optimal Medication Management in Alzheimer's Disease and Dementia$133,398
R21 · FY2018 · AG
Optimal Medication Management in Alzheimer's Disease and Dementia$70,685
R21 · FY2018 · AG
Optimal Medication Management in Alzheimer's Disease and Dementia$303,654
R21 · FY2017 · AG
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring Program$187,938
K24 · FY2017 · AG · contact PI
Treatment Burden in Older Adults with Diabetes and Multimorbidity$114,042
K23 · FY2013 · AG · contact PI
Treatment Burden in Older Adults with Diabetes and Multimorbidity$113,363
K23 · FY2012 · AG · contact PI
Treatment Burden in Older Adults with Diabetes and Multimorbidity$104,005
K23 · FY2011 · AG · contact PI
Treatment Burden in Older Adults with Diabetes and Multimorbidity$94,852
K23 · FY2010 · AG · contact PI
Improving Clinical Practice Guidelines for Complex Patients$236,350
R21 · FY2009 · HS · contact PI
Treatment Burden in Complex Older Patients as a Target for Intervention$158,716
R21 · FY2009 · HS · contact PI
Treatment Burden in Older Adults with Diabetes and Multimorbidity$106,864
K23 · FY2009 · AG · contact PI
Treatment Burden in Complex Older Patients as a Target for Intervention$154,404
R21 · FY2008 · HS · contact PI